Galderma Group AG Ratios and Metrics

Market cap in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '25 Apr 24, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	19,135	23,909	-	-	-
Enterprise Value	21,221	26,211	-	-	-
Last Close Price	80.60	100.64	-	-	-
PE Ratio	91.70	114.22	-	-	-
Forward PE	37.05	43.27	-	-	-
PS Ratio	4.76	5.94	-	-	-
PB Ratio	2.71	3.39	-	-	-
P/FCF Ratio	58.66	73.29	-	-	-
P/OCF Ratio	43.27	54.07	-	-	-
PEG Ratio	0.99	1.02	-	-	-
EV/Sales Ratio	5.27	6.52	-	-	-
EV/EBITDA Ratio	25.45	32.46	-	-	-
EV/EBIT Ratio	34.90	43.11	-	-	-
EV/FCF Ratio	65.05	80.35	-	-	-
Debt / Equity Ratio	0.35	0.35	0.91	1.27	1.25
Debt / EBITDA Ratio	3.00	3.00	5.83	8.68	9.67
Debt / FCF Ratio	7.66	7.66	111.57	583.27	39.02
Asset Turnover	0.35	0.35	0.33	0.31	-
Inventory Turnover	3.29	3.29	2.86	3.03	-
Quick Ratio	0.89	0.89	0.72	0.52	0.55
Current Ratio	1.21	1.21	1.03	0.77	0.82
Return on Equity (ROE)	3.51%	3.51%	-1.16%	-2.15%	-
Return on Assets (ROA)	3.34%	3.34%	3.04%	2.01%	-
Return on Capital (ROIC)	4.03%	4.03%	3.71%	2.46%	-
Return on Capital Employed (ROCE)	6.10%	6.10%	5.60%	3.80%	3.30%
Earnings Yield	1.09%	0.88%	-	-	-
FCF Yield	1.70%	1.36%	-	-	-
Buyback Yield / Dilution	-0.10%	-0.10%	95.42%	-	-

Updated Mar 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.